OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signaling pathways modulated by miRNAs in breast cancer angiogenesis and new therapeutics
Bashdar Mahmud Hussen, Abbas Salihi, Sara Tharwat Abdullah, et al.
Pathology - Research and Practice (2022) Vol. 230, pp. 153764-153764
Closed Access | Times Cited: 24

Showing 24 citing articles:

A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions
Selvaraj Vimalraj
International Journal of Biological Macromolecules (2022) Vol. 221, pp. 1428-1438
Closed Access | Times Cited: 98

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Snur Rasool Abdullah, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 56

Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies
Ramesh Chaudhari, Vishva Patel, Ashutosh Kumar
Nanoscale Advances (2024) Vol. 6, Iss. 9, pp. 2270-2286
Open Access | Times Cited: 19

Novel VEGFR‐2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016–2021)
S. Vishakha, Kumari Kajal, Sitanshu Mondal, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 2
Closed Access | Times Cited: 17

The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer
Mohammed H. Abu-Alghayth, Farhan R. Khan, Tareg M. Belali, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155180-155180
Closed Access | Times Cited: 8

Exploring the role of ITGB6: fibrosis, cancer, and other diseases
Zhe Zhang, Zheng Wang, Tong Liu, et al.
APOPTOSIS (2023) Vol. 29, Iss. 5-6, pp. 570-585
Closed Access | Times Cited: 11

Mesenchymal stem cell exosomes therapy for the treatment of traumatic brain injury: mechanism, progress, challenges and prospects
Ming-wei Liu, Hua Li, Gang Xiong, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Anti-angiogenic drugs in cancer therapeutics: a review of the latest preclinical and clinical studies of anti-angiogenic agents with anticancer potential
Polyxeni Vafopoulou, Malamati Kourti
Journal of Cancer Metastasis and Treatment (2022) Vol. 8, pp. 18-18
Open Access | Times Cited: 17

Interaction between SIRT1 and non-coding RNAs in different disorders
Soudeh Ghafouri‐Fard, Hamed Shoorei, Bashdar Mahmud Hussen, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8

Role of microRNAs in neutrophil extracellular trap formation and prevention: Systematic narrative review
Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Goran Sedeeq Hama Faraj, et al.
Molecular and Cellular Probes (2024) Vol. 78, pp. 101986-101986
Open Access | Times Cited: 2

Identification of miR-125a and miR-106b signature as a potential diagnostic biomarker in breast cancer tissues
Soudeh Ghafouri‐Fard, Bashdar Mahmud Hussen, Solat Eslami
Pathology - Research and Practice (2024) Vol. 256, pp. 155277-155277
Closed Access | Times Cited: 1

Unraveling non-coding RNAs in breast cancer: mechanistic insights and therapeutic potential
Muqtada Shaikh, Gaurav Doshi
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 1

Modulation of miR-204 Expression during Chondrogenesis
Luca Dalle Carbonare, Jessica Bertacco, Arianna Minoia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2130-2130
Open Access | Times Cited: 7

A review on the role of miR-671 in human disorders
Soudeh Ghafouri‐Fard, Arian Askari, Bashdar Mahmud Hussen, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 6

Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?
Marzieh Ramezani Farani, Maryam Sarlak, Amir Gholami, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154688-154688
Closed Access | Times Cited: 3

A review on the role of ncRNAs in the pathogenesis of cholangiocarcinoma
Soudeh Ghafouri‐Fard, Arash Safarzadeh, Bashdar Mahmud Hussen, et al.
International Journal of Biological Macromolecules (2022) Vol. 225, pp. 809-821
Open Access | Times Cited: 5

The thiophene α-terthienylmethanol isolated from Tagetes minuta inhibits angiogenesis by targeting protein kinase C isozymes α and β2
María C. Llorens de los Ríos, Priscila A. Lanza, Cecilia L. Barbieri, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3

MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport Protein GRAMD1B
Katharina Jonas, Felix Prinz, Manuela Ferracin, et al.
Non-Coding RNA (2023) Vol. 10, Iss. 1, pp. 2-2
Open Access | Times Cited: 1

Nanotechnology advances for improved targeting of solid tumors
Rabea Parveen, Naveen Reddy Penumallu, Sayeed Ahmad
Elsevier eBooks (2023), pp. 173-200
Closed Access

A New Insight of MicroRNA-96 In Human Malignant Disorders and Drug Resistance
Zanko Hassan Jawhar, Hozan I. Ibrahim, Yousif Mohammed Younis
Qalaai Zanist Scientific Journal (2023) Vol. 8, Iss. 4
Open Access

New model for intelligent breast cancer monitoring Summary
Mohammad Ali Pourmina, Javad Nouri Pour, Mohammad Naser‐Moghadasi, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top